A total of 869 Ozempic counterfeit pens were seized in 2023
A phase 2, placebo-controlled, randomized, double-blind trial of tozadenant (Syn-115) in patients with Parkinsons disease with wearing-off fluctuations on levodopa
Does VivioMD offer semaglutide
Temperature stability directly affects your dosing outcomes
Velocity Clinical Research, Denver 401 W Hampden Pl Suite 240, Englewood, CO 80110 Phone: (303) 293-3733 Find a Clinical Trial in Denver Use the dropdown to browse current studies in Denver
04, 2026 (GLOBE NEWSWIRE) -- Noom, the leading behavior change company, today shared new real-world findings from tens of thousands of members, showing a clear relationship: members who engage more with Noom's leading GLP-1 Companion app tend to lose more weight and stay on a medication program longer